In contrast, the transfection of a dominant-negative NFAT (DN-NFAT) (Figure 2C) or NFAT1 siRNA (Figure 2D) led to the downregulation of MDM2 expression, which was further enhanced by JapA in both breast cancer cell lines. The gene discussed is MDM2; the disease is breast carcinoma.